The reason is because sodium transporters are more active in pathological conditions (hyperglycemia, mechanical overload, hypertension, obesity, systemic inflammation, ischemia) compared to healthy hearts. This evidence concerns the gene SLC5A4 and obesity due to melanocortin 4 receptor deficiency.